These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 27449999)
1. Antimycobacterial activity of pyrazinoate prodrugs in replicating and non-replicating Mycobacterium tuberculosis. Segretti ND; Simões CK; Corrêa MF; Felli VMA; Miyata M; Cho SH; Franzblau SG; Fernandes JPDS Tuberculosis (Edinb); 2016 Jul; 99():11-16. PubMed ID: 27449999 [TBL] [Abstract][Full Text] [Related]
2. Antimycobacterial activity of a series of pyrazinoic acid esters. Cynamon MH; Klemens SP; Chou TS; Gimi RH; Welch JT J Med Chem; 1992 Apr; 35(7):1212-5. PubMed ID: 1560435 [TBL] [Abstract][Full Text] [Related]
3. QSAR modeling of a set of pyrazinoate esters as antituberculosis prodrugs. Fernandes JP; Pasqualoto KF; Felli VM; Ferreira EI; Brandt CA Arch Pharm (Weinheim); 2010 Feb; 343(2):91-7. PubMed ID: 20099263 [TBL] [Abstract][Full Text] [Related]
4. Lipophilic pyrazinoic acid amide and ester prodrugs stability, activation and activity against M. tuberculosis. Simões MF; Valente E; Gómez MJ; Anes E; Constantino L Eur J Pharm Sci; 2009 Jun; 37(3-4):257-63. PubMed ID: 19491013 [TBL] [Abstract][Full Text] [Related]
5. Esters of Pyrazinoic Acid Are Active against Pyrazinamide-Resistant Strains of Mycobacterium tuberculosis and Other Naturally Resistant Mycobacteria In Vitro and Ex Vivo within Macrophages. Pires D; Valente E; Simões MF; Carmo N; Testa B; Constantino L; Anes E Antimicrob Agents Chemother; 2015 Dec; 59(12):7693-9. PubMed ID: 26438493 [TBL] [Abstract][Full Text] [Related]
6. Synthesis and antituberculosis activity of novel mefloquine-isoxazole carboxylic esters as prodrugs. Mao J; Yuan H; Wang Y; Wan B; Pak D; He R; Franzblau SG Bioorg Med Chem Lett; 2010 Feb; 20(3):1263-8. PubMed ID: 20022500 [TBL] [Abstract][Full Text] [Related]
7. Potential tuberculostatic agent: micelle-forming pyrazinamide prodrug. Silva M; Ricelli NL; El Seoud O; Valentim CS; Ferreira AG; Sato DN; Leite CQ; Ferreira EI Arch Pharm (Weinheim); 2006 Jun; 339(6):283-90. PubMed ID: 16688684 [TBL] [Abstract][Full Text] [Related]
8. Pyrazinoic acid and its n-propyl ester inhibit fatty acid synthase type I in replicating tubercle bacilli. Zimhony O; Vilchèze C; Arai M; Welch JT; Jacobs WR Antimicrob Agents Chemother; 2007 Feb; 51(2):752-4. PubMed ID: 17101678 [TBL] [Abstract][Full Text] [Related]
9. Structure activity relationship of pyrazinoic acid analogs as potential antimycobacterial agents. Hegde PV; Aragaw WW; Cole MS; Jachak G; Ragunathan P; Sharma S; Harikishore A; Grüber G; Dick T; Aldrich CC Bioorg Med Chem; 2022 Nov; 74():117046. PubMed ID: 36228522 [TBL] [Abstract][Full Text] [Related]
10. Pyrazinamide and Pyrazinoic Acid Derivatives Directed to Mycobacterial Enzymes Against Tuberculosis. Corrêa MF; Fernandes JP Curr Protein Pept Sci; 2016; 17(3):213-9. PubMed ID: 26427385 [TBL] [Abstract][Full Text] [Related]
11. Facile synthesis and antimycobacterial activity of isoniazid, pyrazinamide and ciprofloxacin derivatives. Alsayed SSR; Lun S; Payne A; Bishai WR; Gunosewoyo H Chem Biol Drug Des; 2021 Jun; 97(6):1137-1150. PubMed ID: 33638304 [TBL] [Abstract][Full Text] [Related]
12. Derivatives of 3-isoxazolecarboxylic acid esters: a potent and selective compound class against replicating and nonreplicating Mycobacterium tuberculosis. Lilienkampf A; Pieroni M; Franzblau SG; Bishai WR; Kozikowski AP Curr Top Med Chem; 2012; 12(7):729-34. PubMed ID: 22283815 [TBL] [Abstract][Full Text] [Related]
13. Quantitative structure-activity relationships for the in vitro antimycobacterial activity of pyrazinoic acid esters. Bergmann KE; Cynamon MH; Welch JT J Med Chem; 1996 Aug; 39(17):3394-400. PubMed ID: 8765523 [TBL] [Abstract][Full Text] [Related]
14. Design, synthesis and investigation on the structure-activity relationships of N-substituted 2-aminothiazole derivatives as antitubercular agents. Pieroni M; Wan B; Cho S; Franzblau SG; Costantino G Eur J Med Chem; 2014 Jan; 72():26-34. PubMed ID: 24333612 [TBL] [Abstract][Full Text] [Related]
15. Mode of action of pyrazinamide: disruption of Mycobacterium tuberculosis membrane transport and energetics by pyrazinoic acid. Zhang Y; Wade MM; Scorpio A; Zhang H; Sun Z J Antimicrob Chemother; 2003 Nov; 52(5):790-5. PubMed ID: 14563891 [TBL] [Abstract][Full Text] [Related]
16. In vitro antimycobacterial activities of pyrazinamide analogs. Yamamoto S; Toida I; Watanabe N; Ura T Antimicrob Agents Chemother; 1995 Sep; 39(9):2088-91. PubMed ID: 8540721 [TBL] [Abstract][Full Text] [Related]
17. Enhancement of in vitro activity of tuberculosis drugs by addition of thioridazine is not reflected by improved in vivo therapeutic efficacy. de Knegt GJ; ten Kate MT; van Soolingen D; Aarnoutse R; Boeree MJ; Bakker-Woudenberg IA; de Steenwinkel JE Tuberculosis (Edinb); 2014 Dec; 94(6):701-7. PubMed ID: 25621361 [TBL] [Abstract][Full Text] [Related]
18. Synthesis and antimycobacterial activity of prodrugs of sulfur dioxide (SO2). Malwal SR; Sriram D; Yogeeswari P; Chakrapani H Bioorg Med Chem Lett; 2012 Jun; 22(11):3603-6. PubMed ID: 22572576 [TBL] [Abstract][Full Text] [Related]
19. 8-Hydroxyquinolines are bactericidal against Mycobacterium tuberculosis. Odingo JO; Early JV; Smith J; Johnson J; Bailey MA; Files M; Guzman J; Ollinger J; Korkegian A; Kumar A; Ovechkina Y; Parish T Drug Dev Res; 2019 Aug; 80(5):566-572. PubMed ID: 30893501 [TBL] [Abstract][Full Text] [Related]